Balaji Phosphates Ltd

Balaji Phos. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Balaji Phosphates Ltd

₹ 120 -4.84%
03 Dec - close price
balajiphosphates.com NSE - SME: BALAJIPHOS
About

Incorporated in 1996, Balaji Phosphates Limited manufactures and supplies Single Super Phosphate (SSP), NPK Granulated and Mixed Fertilizers, and Zinc Sulphate.[1]

Key Points

Product Portfolio[1]
a) Single Super Phosphate (SSP) – Available in powder and granular forms.
b) NPK Granulated & Mixed Fertilizers – Various grades: 12:32:06, 15:05:05, 16:30:10, 17:17:17, 20:20:00, 10:20:10.
c) Zinc Sulphate – Available in 21% and 33% purity.
d) Fortified SSP with Zinc & Boron – Zincated SSP and Boronated SSP in powder and granular forms.

Website NSE - SM
  • Market Cap ₹ 285 Cr.
  • Current Price ₹ 120
  • High / Low ₹ 185 / 72.6
  • Stock P/E 24.5
  • Book Value ₹ 37.0
  • Dividend Yield 0.00 %
  • ROCE 16.2 %
  • ROE 13.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 25.4% CAGR over last 5 years

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 93.2 to 129 days.
  • Working capital days have increased from 99.9 days to 174 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Fertilizers & Agrochemicals Fertilizers

Edit Columns
Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Sep 2024 Mar 2025 Sep 2025
55 62 64 85
52 56 57 72
Operating Profit 3 6 7 13
OPM % 6% 10% 11% 15%
0 2 0 1
Interest 2 2 2 2
Depreciation 0 0 1 1
Profit before tax 1 6 5 11
Tax % 30% 24% 27% 26%
1 4 4 8
EPS in Rs 0.49 2.43 1.51 3.39
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
59 103 124 145 152 127 149
52 98 116 133 139 113 129
Operating Profit 7 5 8 12 12 13 20
OPM % 12% 5% 6% 8% 8% 11% 13%
1 0 0 0 0 2 1
Interest 2 2 3 3 3 4 4
Depreciation 1 1 1 1 1 1 1
Profit before tax 4 2 5 8 8 11 16
Tax % 43% 45% 30% 26% 28% 26%
3 1 3 6 6 8 12
EPS in Rs 2.27 5.37 6.83 3.39 3.33 4.90
Dividend Payout % 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 17%
3 Years: 1%
TTM: 26%
Compounded Profit Growth
10 Years: %
5 Years: 25%
3 Years: 35%
TTM: 123%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 16%
3 Years: 17%
Last Year: 14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 8 6 6 9 18 24 24
Reserves 11 15 17 20 17 56 64
14 20 20 26 33 31 40
26 32 40 42 20 13 24
Total Liabilities 59 72 82 97 88 124 152
8 13 12 12 12 12 13
CWIP 0 0 0 0 0 1 6
Investments 0 0 0 0 0 0 0
52 59 70 85 77 111 134
Total Assets 59 72 82 97 88 124 152

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
6 7 3 -4 3 -36
-0 -7 -1 -0 -8 5
-6 1 -2 4 4 31
Net Cash Flow -0 1 0 0 -1 0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 149 93 91 76 75 129
Inventory Days 196 116 94 152 106 173
Days Payable 169 125 74 70 33 31
Cash Conversion Cycle 175 83 112 157 148 271
Working Capital Days 102 48 49 58 67 174
ROCE % 12% 18% 22% 19% 16%

Shareholding Pattern

Numbers in percentages

Mar 2025Sep 2025
69.90% 69.90%
3.55% 3.54%
1.35% 0.77%
25.20% 25.79%
No. of Shareholders 583347

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP